Omeros to Present at Two Upcoming Conferences
Today 7:00 EDT
from PR Newswire
Traders in Omeros Attributing Upside in Shares to Bullish Note from MLV & Co., Says Trend Higher 'Will Continue'
May 14, 2013
from PR Newswire
Short Interest Jumps 41.2% For OMER
May 10, 2013
The most recent short interest data has been released by the NASDAQ for the 04/30/2013 settlement date, which shows a 1,529,276 share increase in total short interest for Omeros Corp (OMER), to... Read More
category
Stocks
from Market News Video
from PR Newswire
from PR Newswire
Omeros Corp. (OMER) Reports In-Line Q1 EPS
May 09, 2013
Trading Radar for 05/09: priceline.com (PCLN), NVIDIA (NVDA), DISH Network (DISH), Dean Foods (DF) Report
May 08, 2013
Omeros Requests Fast Track Designation for OMS824 for the Treatment of Huntington's Disease
May 01, 2013
from PR Newswire
Omeros Ophthalmology Product OMS302 Granted Eligibility for European Centralized Review
April 30, 2013
from PR Newswire
Omeros Reports OMS302 Clinical Data Presented at the Annual ASCRS and ASOA Symposium and Congress
April 25, 2013
-- Data Show that OMS302 Maintains Pupil Size During Lens Replacement Surgery by Not Only Promoting Mydriasis but also by Preventing Miosis -- Read More
from PR Newswire
from PR Newswire
Omeros to Present Additional OMS302 Clinical Data at the Annual ASCRS and ASOA Symposium and Congress
April 19, 2013
from PR Newswire
WBB Pounds the Table on Omeros Following Orphan Drug Status, Maintains Strong Buy Rating, $20 Target
April 18, 2013
Omeros Files Orphan Drug Application for Treatment of Atypical Hemolytic Uremic Syndrome with OMS721
April 17, 2013
-- Orphan Drug Designation Could Provide Financial Incentives and Faster Regulatory Review -- Read More
from PR Newswire
MLV & Co. Starts Omeros Corp. (OMER) at Buy
April 15, 2013
Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
April 10, 2013
from PR Newswire
Friday – Market Collapsing on Disastrous Jobs Number
April 05, 2013
from Wall Street Greek
Omeros (OMER) Issues Encouraging Update for OMS721
April 02, 2013
from PR Newswire
from PR Newswire
Omeros (OMER) Toxicology Data Supports MASP-2 Advancement
March 28, 2013
Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials
March 28, 2013
-- European Clinical Trial Application Submission Expected in the Second Quarter of 2013 -- Read More
from PR Newswire
Top Bearish Stocks Under $5 - Stereotaxis (NASDAQ:STXS), Omeros (NASDAQ:OMER), Star Scientific, (NASDAQ:STSI)
March 27, 2013
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here